National Registry and Cohort Study of Pulmonary Vascular Disease (NCPVD)

Nanjing Medical University

Status: Enrolling

Conditions: Pulmonary Arterial Hypertension

Treatments: Combination Product: The clinical course and disease management

Study type: Observational

Funder types: Other

Identifiers

NCT05368467

NMU20220505

Details and patient eligibility

About

This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Newly diagnosed or previously diagnosed patients with PH.
• Documentation of mean pulmonary arterial pressure (mPAP) >20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.

Exclusion criteria

• Have not had documentation of hemodynamic criteria for PH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PH.
• Do not meet the required hemodynamic criteria for entry into the study.

Trial design

1,000 participants in 1 patient group

1

Description:

All consecutive consenting patients diagnosed with PH according to specific hemodynamic criteria at participating institutions.

Treatment:

Combination Product: The clinical course and disease management